Article
Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer
2023-02-26
Abstract excerpt
<h4>ABSTRACT</h4> Breast and ovarian cancers harboring homologous recombination deficiencies (HRD) can benefit from platinum-based chemotherapies and PARP inhibitors. Standard diagnostic tests for detecting HRD utilize molecular profiling, which is not universally available especially for medically underserved populations. Here, we trained a deep learning approach for predicting genomically derived HRD scores fro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 873ac60a-c54c-5a4a-8972-8386f1461a78
- DOI
- 10.1101/2023.02.23.23285869
